跳至主要内容
临床试验/NCT01450540
NCT01450540已完成不适用

Automated Graduated CPAP (AGPAP) for Improved Adherence in Newly Diagnosed OSA Patients: Multicenter Trial

Philips Respironics9 个研究点 分布在 1 个国家目标入组 241 人开始时间: 2011年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
241
试验地点
9
主要终点
CPAP Adherence

研究概览

简要总结

Although positive airway pressure (PAP) is a highly effective treatment for sleep apnea, adherence to therapy remains an obstacle. Automated Graduated CPAP (AGPAP), also know as EZ-start, is an extended duration ramp, where the patient receives pressure below their prescription during an acclimation phase. The algorithm gradually increases pressure to therapy level based on usage. The aim of this study was to determine the effectiveness of the AGPAP acclimation period and its impact on short term adherence.

详细描述

Even though CPAP is highly effective in treating sleep apnea, adherence to CPAP therapy remains the largest single obstacle to the successful resolution of sleep-disordered breathing in OSA patients. It has been estimated that up to 50% of patients who have been prescribed CPAP for Obstructive Sleep Apnea (OSA) are not using the treatment one year later. A myriad of possible causes for low compliance rates have been proposed and examined in previous studies. These include race, gender, education level, income, bed-partner's sleep quality, mask discomfort, continuity of care, nasal irritation, discomfort due to elevated expiratory pressure, and level of daytime sleepiness.

Therefore, many investigators have proposed new methods and approaches to help deal with these problems. Interventions have ranged from people-centric approaches using intensive CPAP education and follow-up programs, to device modifications using features such as a ramp, C-FLEX®, BiLevel therapy, and heated humidification.

In this study. The aim of this study was to determine the effectiveness of the Automated Graduated CPAP (AGPAP), also know as EZ-start acclimation period, and its impact on short term adherence

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
25 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Newly diagnosed with OSA (last 12 weeks)
  • Prescribed continuous positive airway pressure (CPAP) pressure ≥ 10 cmH2O
  • Willing and able to provide informed consent
  • Able to follow instructions

排除标准

  • Participation in another interventional research study within the last 30 days
  • Major controlled or an uncontrolled medical condition such as congestive heart failure, neuromuscular disease, renal failure, cancer, chronic obstructive pulmonary disease (COPD), respiratory failure or insufficiency, or patients requiring oxygen therapy (as determined by self-report and reviewed by the study PI.)
  • Prior PAP prescription, use, or any prior OSA treatment, excluding split-night or titration PAP exposure.
  • Prescribed BiLevel therapy
  • Presence of untreated, non-OSA related sleep disorders (e.g. moderate to severe restless legs (PLMAI ≥ 20) or insomnia)
  • History of an automobile accident or near accident in the last 12 months due to sleepiness.
  • Severe oxygen desaturation on the PSG (Sa02 < 70% for 10% of the diagnostic PSG study).
  • Surgery of the upper airway, nose, sinus, or middle ear within the past 90 days
  • Regular use (>3 nights per week) of sleeping pills or stimulants.
  • Currently working a night shift or rotating day/night shift.
  • Unwillingness to try PAP at home.
  • Presence of tracheostomy

结局指标

主要结局

CPAP Adherence

时间窗: 3 months

Device usage (hours per night)

次要结局

  • Functional Outcome Sleep Quality (FOSQ)(3 months)
  • Daytime Sleepiness as Measured by the Epworth Sleepiness Scale(3 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (9)

Loading locations...

相似试验

Automated Graduated CPAP (AGPAP) for Improved... | 临床试验